 NEW YORK, NY, Dec. 28, 2020 GLOBE NEWSWIRE -- Enzo Biochem, Inc. NYSE:ENZ Enzo or The Company, a leading biosciences and diagnostics company, announced today that it has reviewed the position of Institutional Shareholder Services ISS regarding the Companys executive compensation approach for the fiscal year ended July 31, 2020. To acknowledge and address the issues within the ISS report, Dr. Elazar Rabbani, the Companys Chairperson and CEO, has requested the Compensation Committee of the Companys Board of Directors not to pay his previously announced bonus in cash. In lieu thereof, he has requested such bonus be paid in common stock of Enzo based on the closing price of the Companys shares on the date of issuance. Mr. Barry Weiner, the Companys President, followed Dr. Rabbanis lead and made a similar request of the Compensation Committee. The Company stated the Compensation Committee has agreed to such requests and that Dr. Rabbani and Mr. Weiner have agreed to hold the common stock paid as bonus for at least three years post issuance. 